Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Immunohistochemical and molecular biologic techniques were used to delineate the prevalence of (1) the ras oncogene, (2) p53, and (3) the ret/PTC oncogene in the development of differentiated thyroid cancer from normal cells and hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP691392.RAAm07Q58lv5D3NsfESJYeA1vtqiZv1y-NUq8GijsT6tU130_assertion description "[Immunohistochemical and molecular biologic techniques were used to delineate the prevalence of (1) the ras oncogene, (2) p53, and (3) the ret/PTC oncogene in the development of differentiated thyroid cancer from normal cells and hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691392.RAAm07Q58lv5D3NsfESJYeA1vtqiZv1y-NUq8GijsT6tU130_provenance.
• NP808958.RATl36hHH65_2oQoCeBqFqSzQo98IAbdDtMGG0RgYCxQU130_assertion description "[Immunohistochemical and molecular biologic techniques were used to delineate the prevalence of (1) the ras oncogene, (2) p53, and (3) the ret/PTC oncogene in the development of differentiated thyroid cancer from normal cells and hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP808958.RATl36hHH65_2oQoCeBqFqSzQo98IAbdDtMGG0RgYCxQU130_provenance.
• NP758044.RATKh4zZVkfX2JX83Q2j0jWxM1qLenBGgUkrewKaiRCoc130_assertion description "[Immunohistochemical and molecular biologic techniques were used to delineate the prevalence of (1) the ras oncogene, (2) p53, and (3) the ret/PTC oncogene in the development of differentiated thyroid cancer from normal cells and hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP758044.RATKh4zZVkfX2JX83Q2j0jWxM1qLenBGgUkrewKaiRCoc130_provenance.
• NP408524.RA37if6FysPpgrK7jZcFdxYYjM1eE4i105c25pJ2eBHfg130_assertion description "[Immunohistochemical and molecular biologic techniques were used to delineate the prevalence of (1) the ras oncogene, (2) p53, and (3) the ret/PTC oncogene in the development of differentiated thyroid cancer from normal cells and hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP408524.RA37if6FysPpgrK7jZcFdxYYjM1eE4i105c25pJ2eBHfg130_provenance.
• NP382665.RA_PrPzDjOs69i-80r38Unrx3uHIlSoxMonzbkcaSJS2o130_assertion description "[Immunohistochemical and molecular biologic techniques were used to delineate the prevalence of (1) the ras oncogene, (2) p53, and (3) the ret/PTC oncogene in the development of differentiated thyroid cancer from normal cells and hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP382665.RA_PrPzDjOs69i-80r38Unrx3uHIlSoxMonzbkcaSJS2o130_provenance.
• NP461556.RA1RPgwGKKts0ZaGLuMBZPtSjC6vfjioKdDGLJywx93SI130_assertion description "[Immunohistochemical and molecular biologic techniques were used to delineate the prevalence of (1) the ras oncogene, (2) p53, and (3) the ret/PTC oncogene in the development of differentiated thyroid cancer from normal cells and hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP461556.RA1RPgwGKKts0ZaGLuMBZPtSjC6vfjioKdDGLJywx93SI130_provenance.
• NP392722.RAYc1-xc1BMufHU1qSoinN0ccrOS6BdFRYqwk30U0Q-hY130_assertion description "[Immunohistochemical and molecular biologic techniques were used to delineate the prevalence of (1) the ras oncogene, (2) p53, and (3) the ret/PTC oncogene in the development of differentiated thyroid cancer from normal cells and hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP392722.RAYc1-xc1BMufHU1qSoinN0ccrOS6BdFRYqwk30U0Q-hY130_provenance.
• NP368396.RASrVYab4uVE-vYk-3l1sdxG5HMGzUT5xGjneXsIBD-Do130_assertion description "[Immunohistochemical and molecular biologic techniques were used to delineate the prevalence of (1) the ras oncogene, (2) p53, and (3) the ret/PTC oncogene in the development of differentiated thyroid cancer from normal cells and hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP368396.RASrVYab4uVE-vYk-3l1sdxG5HMGzUT5xGjneXsIBD-Do130_provenance.
• NP368398.RAWIIMks9dXRY24_x3f9vQofZbPguXsk_8NewR4Wrod4s130_assertion description "[Immunohistochemical and molecular biologic techniques were used to delineate the prevalence of (1) the ras oncogene, (2) p53, and (3) the ret/PTC oncogene in the development of differentiated thyroid cancer from normal cells and hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP368398.RAWIIMks9dXRY24_x3f9vQofZbPguXsk_8NewR4Wrod4s130_provenance.
• NP653568.RAAxzuvZO6RWIp9Xup2rSI9HNeNg3SXlJQCEecjGCbvQQ130_assertion description "[Immunohistochemical and molecular biologic techniques were used to delineate the prevalence of (1) the ras oncogene, (2) p53, and (3) the ret/PTC oncogene in the development of differentiated thyroid cancer from normal cells and hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP653568.RAAxzuvZO6RWIp9Xup2rSI9HNeNg3SXlJQCEecjGCbvQQ130_provenance.
• NP671281.RApDM4sWx7fovtYEk0VNUtH3CzUgAwNbXGnFYX-ynSvyA130_assertion description "[Immunohistochemical and molecular biologic techniques were used to delineate the prevalence of (1) the ras oncogene, (2) p53, and (3) the ret/PTC oncogene in the development of differentiated thyroid cancer from normal cells and hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671281.RApDM4sWx7fovtYEk0VNUtH3CzUgAwNbXGnFYX-ynSvyA130_provenance.
• NP788614.RAtoW_dAa8Vclxl0ZWu8_lDAwGbYR5AUcVAYWftlz-Hhw130_assertion description "[Immunohistochemical and molecular biologic techniques were used to delineate the prevalence of (1) the ras oncogene, (2) p53, and (3) the ret/PTC oncogene in the development of differentiated thyroid cancer from normal cells and hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP788614.RAtoW_dAa8Vclxl0ZWu8_lDAwGbYR5AUcVAYWftlz-Hhw130_provenance.
• NP368402.RAkwLbE1oDqTH2RAuQ5YMfH4ma_y4AKMMU0NC_jaJOTrE130_assertion description "[Immunohistochemical and molecular biologic techniques were used to delineate the prevalence of (1) the ras oncogene, (2) p53, and (3) the ret/PTC oncogene in the development of differentiated thyroid cancer from normal cells and hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP368402.RAkwLbE1oDqTH2RAuQ5YMfH4ma_y4AKMMU0NC_jaJOTrE130_provenance.
• NP368409.RAtvAwmNDIC_pVLQEP0z0M6AxytDRAzLsz-LPDFLDTX8E130_assertion description "[Immunohistochemical and molecular biologic techniques were used to delineate the prevalence of (1) the ras oncogene, (2) p53, and (3) the ret/PTC oncogene in the development of differentiated thyroid cancer from normal cells and hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP368409.RAtvAwmNDIC_pVLQEP0z0M6AxytDRAzLsz-LPDFLDTX8E130_provenance.
• NP653089.RA-zrqLFE56euQrXlzc1f4_H2esIj8DhCoCrUtBkliybw130_assertion description "[Immunohistochemical and molecular biologic techniques were used to delineate the prevalence of (1) the ras oncogene, (2) p53, and (3) the ret/PTC oncogene in the development of differentiated thyroid cancer from normal cells and hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP653089.RA-zrqLFE56euQrXlzc1f4_H2esIj8DhCoCrUtBkliybw130_provenance.
• NP368404.RANWiNOevFuLUU0HUqn6wgCG7_P4PBDK9DcV7CwwIhu14130_assertion description "[Immunohistochemical and molecular biologic techniques were used to delineate the prevalence of (1) the ras oncogene, (2) p53, and (3) the ret/PTC oncogene in the development of differentiated thyroid cancer from normal cells and hyperplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP368404.RANWiNOevFuLUU0HUqn6wgCG7_P4PBDK9DcV7CwwIhu14130_provenance.